lifevantage is at the forefront of nutrigenomics, a new form of nutritional science that uses nutrients to create improved health and wellness. aging is inevitable. and we’re all painfully aware of the toll it takes on our bodies. nutrigenomics is serious science. and it’s graduated from the laboratory to real-life, creating a platform for products that really work – really.
Company profile
Ticker
LFVN
Exchange
Website
CEO
Darren Jensen
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
LIFELINE THERAPEUTICS, INC., YAAK RIVER RESOURCES INC
SEC CIK
Corporate docs
Subsidiaries
Dinng Creative, Inc. • Importadora LifeVantage S. de R.L. de C.V. • LFVN Malaysia SDN. BHD. • LifeLine Nutraceuticals Corporation • LifeVantage Asia Pte. Ltd. • LifeVantage Australia • LifeVantage Canada Ltd. • LifeVantage de Mexico • LifeVantage Hong Kong Limited • LifeVantage Netherlands B.V. ...
IRS number
841097796
LFVN stock data
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
15 Feb 24
8-K
LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2024
30 Jan 24
10-Q
2024 Q2
Quarterly report
30 Jan 24
8-K/A
Submission of Matters to a Vote of Security Holders
13 Nov 23
8-K
Submission of Matters to a Vote of Security Holders
9 Nov 23
8-K
LifeVantage Announces Financial Results for the First Quarter of Fiscal 2024
9 Nov 23
10-Q
2024 Q1
Quarterly report
9 Nov 23
DFAN14A
Additional proxy materials by non-management
1 Nov 23
DFAN14A
Additional proxy materials by non-management
30 Oct 23
DEFA14A
Additional proxy soliciting materials
30 Oct 23
Transcripts
LFVN
Earnings call transcript
2024 Q2
30 Jan 24
LFVN
Earnings call transcript
2024 Q1
9 Nov 23
LFVN
Earnings call transcript
2023 Q4
28 Aug 23
LFVN
Earnings call transcript
2023 Q3
4 May 23
LFVN
Earnings call transcript
2023 Q2
2 Feb 23
LFVN
Earnings call transcript
2023 Q1
2 Nov 22
LFVN
Earnings call transcript
2022 Q4
23 Aug 22
LFVN
Earnings call transcript
2022 Q3
4 May 22
LFVN
Earnings call transcript
2022 Q2
1 Feb 22
LFVN
Earnings call transcript
2022 Q1
8 Nov 21
Latest ownership filings
4
Darwin Lewis
18 Mar 24
4
Judd Dayton
28 Feb 24
4
Julie Boyster
21 Feb 24
SC 13D/A
Sudbury Capital Management, LLC
15 Feb 24
SC 13D/A
Radoff Bradley Louis
15 Feb 24
SC 13G/A
RENAISSANCE TECHNOLOGIES LLC
13 Feb 24
4
Garry Paul Mauro
6 Feb 24
4
Steven R Fife
3 Jan 24
4
Carl Aure
3 Jan 24
4
Julie Boyster
3 Jan 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jun 23 | Jun 22 | Jun 21 | Jun 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 18.41 mm | 18.41 mm | 18.41 mm | 18.41 mm | 18.41 mm | 18.41 mm |
Cash burn (monthly) | 1.07 mm | (no burn) | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 6.34 mm | n/a | n/a | n/a | n/a | n/a |
Cash remaining | 12.07 mm | n/a | n/a | n/a | n/a | n/a |
Runway (months of cash) | 11.3 | n/a | n/a | n/a | n/a | n/a |
Institutional ownership, Q3 2023
29.1% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 54 |
Opened positions | 12 |
Closed positions | 7 |
Increased positions | 11 |
Reduced positions | 15 |
13F shares | Current |
---|---|
Total value | 12.79 bn |
Total shares | 3.75 mm |
Total puts | 0.00 |
Total calls | 25.10 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Renaissance Technologies | 840.12 k | $5.42 mm |
Sudbury Capital Fund | 732.82 k | $3.68 mm |
Vanguard | 462.21 k | $2.98 bn |
Dimensional Fund Advisors | 281.63 k | $1.82 bn |
Acadian Asset Management | 229.94 k | $1.48 mm |
BLK Blackrock | 205.25 k | $1.32 bn |
Geode Capital Management | 116.79 k | $753.47 mm |
Bridgeway Capital Management | 114.13 k | $736.11 mm |
Millennium Management | 89.18 k | $575.19 mm |
Perkins Capital Management | 76.11 k | $491.00 k |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Mar 24 | Darwin Lewis | Common Stock | Buy | Acquire P | No | Yes | 6.9356 | 9 | 62.42 | 107,502 |
15 Mar 24 | Darwin Lewis | Common Stock | Buy | Acquire P | No | Yes | 6.9999 | 440 | 3.08 k | 107,493 |
26 Feb 24 | Judd Dayton | Common Stock | Grant | Acquire A | No | No | 6 | 12,396 | 74.38 k | 25,812 |
2 Feb 24 | Garry Paul Mauro | Common Stock | Buy | Acquire P | Yes | No | 5.71 | 37 | 211.27 | 6,475 |
2 Feb 24 | Garry Paul Mauro | Common Stock | Buy | Acquire P | No | No | 5.66 | 162 | 916.92 | 77,067 |
10 Jan 24 | Garry Paul Mauro | Common Stock | Gift | Acquire G | Yes | No | 0 | 5,000 | 0.00 | 32,542 |
10 Jan 24 | Garry Paul Mauro | Common Stock | Gift | Acquire G | Yes | No | 0 | 5,000 | 0.00 | 32,542 |
10 Jan 24 | Garry Paul Mauro | Common Stock | Gift | Acquire G | Yes | No | 0 | 5,000 | 0.00 | 32,542 |
10 Jan 24 | Garry Paul Mauro | Common Stock | Gift | Acquire G | Yes | No | 0 | 5,000 | 0.00 | 32,542 |
10 Jan 24 | Garry Paul Mauro | Common Stock | Gift | Acquire G | Yes | No | 0 | 5,000 | 0.00 | 32,542 |
News
LifeVantage Introduces The TrueScience Activated Skin Care Collection
4 Mar 24
LifeVantage Announces Expansion Of LV360 Into Canada, Mexico, And European Markets
7 Feb 24
Lifevantage Q2 Adj EPS $0.10 Beats $0.04 Estimate, Sales $51.62M Miss $54.65M Estimate
30 Jan 24
Earnings Scheduled For January 30, 2024
30 Jan 24
Earnings Outlook For Lifevantage
29 Jan 24
Press releases
LifeVantage to Participate in the Winter Wrap Up MicroCap Rodeo Conference
16 Feb 24
LifeVantage Announces Expansion of LV360 into Canada, Mexico, and European Markets
7 Feb 24
LifeVantage Declares Quarterly Dividend
30 Jan 24
LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2024
30 Jan 24
LifeVantage to Announce Second Quarter Fiscal Year 2024 Results on January 30, 2024
16 Jan 24